(Q47892004)

English

Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Huang Y

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

Liu XQ

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

Rall SC Jr

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

Mahley RW

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

273

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

28

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

17483-17490

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

Polymorphism of apolipoprotein E

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Impaired very low density lipoprotein and triglyceride removal in broad beta disease: Comparison with endogenous hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.28.17483

21 January 2018

Identifiers

10.1074/JBC.273.28.17483

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/9651338

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47892004&oldid=2174873443"